Navigation Links
Ronald P. Stanton gives $50 million toward cancer care at NewYork-Presbyterian Hospital
Date:2/11/2009

NEW YORK (Feb. 11, 2009) -- NewYork-Presbyterian Hospital announced today that it has received a $50 million commitment from noted business leader, longtime supporter and Hospital Trustee Ronald P. Stanton. The gift will establish the Ronald P. Stanton Clinical Cancer Program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, strengthening and expanding the Hospital's ability to provide patients with the very best cancer care.

"Philanthropic support for our Hospital's clinical and research programs is always important, but never more so than in these uncertain financial times. We are grateful to Ron Stanton for his outstanding record of support and generosity over many years, and for his latest gift that will do so much to enhance care for cancer patients," says John Mack, chairman of the Board of Trustees of NewYork-Presbyterian Hospital.

Mr. Stanton has a long history of support for NewYork-Presbyterian. In total, he has contributed $75 million, mostly geared to the advancement of cancer care. His most recent philanthropy will help enhance the Hospital's radiation therapy capabilities by making possible the purchase and installation of state-of-the-art equipment, such as new linear accelerators. This new technology delivers radiation with amazing precision, while minimizing, even eliminating, damage to healthy tissue. The gift will allow for the creation of a cutting-edge infusion center with technologies including fast-track chairs for injections and apheresis chairs for whole-blood donations. It will also help recruit world-class physicians in various cancer specialties for further expansion of clinical programs and research initiatives.

His leadership has also helped make possible the modernization of the Hospital, including construction of the Greenberg Pavilion at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the recruitment of cancer-related clinicians, and the establishment of an endowment for the Hospital's Lung Cancer Center. He has also supported rehabilitation medicine and the Iris Cantor Women's Health Center at NewYork-Presbyterian/Weill Cornell, as well as urological fellows at Weill Cornell Medical College. Mr. Stanton joined the board of New York Hospital in 1983. And in the decade since the completion of the merger with The Presbyterian Hospital, he has been an active member of the NewYork-Presbyterian Hospital Board of Trustees.

"NewYork-Presbyterian Hospital is an enormous asset to the greater New York community with its outstanding staff and leadership," says Mr. Stanton. "It is a pleasure to help it carry out its mission by supporting the clinical cancer program. I hope that this contribution will encourage others to offer their financial support to the Hospital as well."

"A diagnosis of cancer can be devastating for patients and their families. This remarkable gift will help our Hospital keep its promise to provide the best available treatments in a comforting and compassionate environment," says Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital. "While the number of Americans dying from cancer has started to decline, there remains much more work to be done, and NewYork-Presbyterian will not stop fighting the war against cancer until it is won."

Mr. Stanton is the founder and chairman of Transammonia Inc. The company trades, distributes and transports fertilizer materials, liquefied petroleum gases and petrochemicals. Mr. Stanton has generously supported numerous educational and cultural organizations. In 1982, he received an honorary Doctor of Humane Letters from Yeshiva University.


'/>"/>

Contact: Kathleen Robinson
krobinso@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. Elephant Ensemble Theater Launches New Tour at the Ronald McDonald House in Long Island
2. PR Newswire Provides Grant to Ronald McDonald House and Habitat for Humanity in Cleveland
3. Ronald McDonald House at Stanford Bids a Holiday Goodbye to Longest Residents
4. Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times
5. Ronald McDonald House Charities(R) of the New York Tri-State Area to Award Over $500,000 in Scholarships to Graduating High School Seniors
6. Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame.
7. Trailblazing pain pioneer Ronald Melzack to be inducted into Medical Hall of Fame
8. Wisconsin Farmer Ronald Kusiak Honored With 2008 Jacobson Memorial Award
9. Ronald McDonald House Charities(R) Awards of Excellence Honors Peter and Virginia Ueberroth, Dr. Catherine D. Deangelis and Lionel Whitehead
10. Car Donations: "Tired Wheels" Turned Into Donation Dollars for Ronald McDonald House Charities, San Diego
11. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 30, 2016 , ... World Patent Marketing ... Up Springboard, an automotive invention that improves the storage features of a pick ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Over ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
Breaking Medicine Technology: